Metabolic dysfunction-associated steatohepatitis (MASH) is the leading cause of chronic liver disease and fibrosis, yet no approved therapies directly reverse fibrogenesis. Current approaches mainly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results